Popular Articles

Health And Safety Executive Warns Of Dangers In Failing To Maintain Plant Equipment After Driver's Death, UK
The Health and Safety Executive has warned of the danger of not maintaining plant equipment after the death of a telescopic forklift truck driver, who was crushed between the descending arm and side of his vehicle.

EULAR Highlights The Impact Of Lupus On Patients' Lives
Results from an international online survey, carried out by UCB in conjunction with Lupus Europe and the Lupus Foundation of America, the two principal advocacy groups that represent people with lupus, were presented during the EULAR (European League Against Rheumatism) congress at a symposium called, "Lupus - considering the future."
News of the day
DOR BioPharma Receives FDA Orphan Drug Designation For OrBec(R) For The Treatment Of Chronic Gastrointestinal GVHD
DOR BioPharma, Inc., (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biopharmaceutical company, announced today that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Oral BDP (beclomethasone 17,21-dipropionate, or orBec((R))) for the treatment of gastrointestinal symptoms associated with chronic Graft-versus-Host disease (cGVHD) in patients who have undergone allogeneic hematopoietic cell transplantation.
Public Health

"What Must EPS Pilot Prove?" Asks NPA

The NPA is asking its members to utilise the new NPA IT forums website to comment on the criteria that should be used to demonstrate that EPS is operationally functional ahead of national roll-out. The NPA believes that EPS must work technically, be business and operationally functional, improve service delivery at pharmacies, and is safe for patients, before full roll-out can be contemplated. The website, http://itforums.npa.co.uk, provides an opportunity for members throughout the UK to voice their opinions on the IT programmes affecting their country or on general IT topics which affect all nations. Gareth Jones, NPA NHS Liaison Manager said: "The NPA is playing an active role in shaping the development of how pharmacy IT programmes will roll out. The IT forums website, we hope, will stimulate debate and give us another way of collecting members" views and concerns about the new programmes being implemented." "We would like active discussion from members on EPS in England, EPES in Northern Ireland, the epharmacy programme in Scotland and 2DRx in Wales. It is important to recognise that effective IT will be increasingly important if community pharmacy is going to meet its future challenges. The NPA has used the forum to re-state its position on EPS and in the next few weeks will be adding EPS dispensary workflows for debate, and asking participants about how they would like to see PMR systems develop. The NPA wants to encourage dialogue on what all these issues will mean for the pharmacist and the pharmacy team and this website provides a platform for that." National Pharmacy Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):